FDA-approved patient labeling STAXYN® (stax-in) • Or any family members have a rare heart condition known as prolongation of the QT (vardenafil HCl) orally disintegrating tablets • Have liver problems. • Have kidney problems and require dialysis. Read the Patient Information about STAXYN before you start taking it and again each time you get a refill. There may be new in
Bardzo tanie apteki z dostawą w całej Polsce kupic levitra i ogromny wybór pigułek.
Wfno2009.umin.ne.jpLisf of Poster Presenters
CD133： Still a marker of brain tumor stem cells？ CD133 negative glioma subpopulations grouped by different cell type markers display tumorgenicity in vivo.
Novel technique for establishment of glioblastoma stem cell line and pathological verification of distribution and differentiation stage of tumor cells on its xenograft.
Therapeutic effect of genetically engineered mesenchymal stem cells in rat experimental leptomeningeal glioma Chloroquine suppresses glioma cell viability and sensitizes radioresistant stem-like glioma cells to ionizing Establishment and characterization of an experimental model of invasive glioma with highly radioresistant Functional results after resection of glioma involving the supplementary motor area The diagnostic impact of radical resection in the management of low-grade glioma Experience with spectroscopy-supported stereotactic brain biopsy Usefulness of FDG-PET-CT-guided stereotactic biopsy for brain tumors Neuronavigation and brain biopsy. Surgical technique and comparison with traditional estereotaxic method.
The role of diffusion tensor image of the tumor resection Usefulness of fiber tract navigation in tumor surgery adjacent to eloquent area Preoperative functional imaging and intraoperative monitoring for improving resection rate of gliomas and Awake Craniotomy and Electrophysiological Mapping in a High Field Intra-Operative MRI New intraoperative MRI system in brain tumor surgery Novel Surgical technique of radical removal for gliomas DISSECTION AND SEPARATION OF HIGH GRADE GLIAL TUMORS FROM BRAIN TISSUE BY USING METHALIC DISSECTOR WITH THE CAPABILITY OF PRODUCING VIBRATION THE OPERATION OF PIAL SYNANGIOSIS IN THE SURGICAL TREATMENT OF MALIGNANT The Clinical Results of Five Cases of Insular Tumor Resection Keyhole surgery in the treatment of gliomas Significance of porphyrins in blood and urine of brain tumor patients that underwent 5-ALA administration Electroloaded dendritic cells with whole tumor lysate elicit enhanced induction of tumor-specific IFNγ producing cells in patients with glioblastoma Cytotoxic T lymphocytes induction with HLA-A2402-restricted glioma specific peptides Characterization of a novel tumor-associated antigen for targeted toxin therapy in gliomas.
Tumoricidal bystander effect-mediated suicide gene therapy of glioma using genetically engineered bone An efficient targeted gene therapy using brain tumor-specific promoter LONG-TERM OUTCOME OF 23 CONSECUTIVE CHILDREN WITH PRIMARY INTRADURAL SPINAL TUMORS TREATED AT THE MEDICAL UNIVERSITY OF VIENNA (1997-2008) Effectiveness of multi-staged operations with combined chemotherapies for huge malignant infantile brain WHICH THERAPY WORKS BETTER IN METASTATIC CHOROID PLEXUS CARCINOMAS? 99 Tc Sestamibi scan differentiates tumor from other contrast enhancing tissue in choroid plexus tumors - Case Adjuvant chemoradiation for mixed germ cell tumors OVER A 10-YEAR SURVIVAL AND COMPLETE RESPONSE OF A PATIENT WITH DIFFUSE INTRINSIC BRAINSTEM GLIOMA (DBSG) TREATED WITH ANTINEOPLASTONS (ANP) Improved response of pontine glioma with simultaneous radiochemotherapy: results of a retrospective image Tactics For Diagnosis and Surgical Treatment of Brain Stem Tumors Profile of Patients with Medulloblastoma at the Philippine General Hospital: a Six-Year Review Results of treatment for medulloblastoma in our institute Can absolute lymphocyte count really be a prognostic indicator for overall survival in patients with Integrating Complexity, Therapeutic Recreation, and Radiotherapy in Multidisciplinary Medical Team on Reducing Anesthesia/Sedation Requirement for Toddlers and Young Children with Brain Tumor Implications of Complexity: Leisure Participation on Primary Caregivers and Hospitalized Children with Brain May13 (Wed)
Endothelial Cell Transdifferentiation of Human Glioma Stem/ Progenitor Cells In vitro The New Diagnosis and Treament of Pituitary Apoplexy THE MIR-17/92 POLYCISTRON IS AMPLIFIED AND UP-REGULATED IN SONIC HEDGEHOG- DRIVEN MEDULLOBLASTOMAS AND INDUCED BY N-MYC IN SONIC HEDGEHOG-TREATEDCEREBELLAR NEURAL PRECURSORS MULTIPLE RECURRENT GENETIC EVENTS CONVERGE ON CONTROL OF HISTONE LYSINE MEDIP-CHIP AND MEDIP-SEQ IDENTIFY NOVEL EPENDYMOMA TUMOUR SUPPRESSOR GENES THROUGH DELINEATION OF THE EPENDYMOMA EPIMETHYLGENOME Clinical Diagnosis of Optic Nerve Hemangioblastoma Gene expression meta-analysis identifies grading and survival markers in anaplastic glioma Multiparameteric MR approach for tissue characterization of patients with GBM NG2 Expression Establishes a Link Between Neural Precursors and Cancer Stem Cells in Glioblastoma UNUSUAL CASE OF RADIATION-INDUCED GROWING TERATOMA SYNDROME Causes and correlates of distress and major depression in high-grade glioma BEVACIZUMAB PLUS ERLOTINIB IN RECURRENT HIGH-GRADE GLIOMA: A PHASE II TRIAL PATIENT FUNCTIONAL STATUS IS STRONGEST CORRELATE OF CHALLENGING BEHAVIOUR Detailed prospective neuropsychological, activity of daily living and endocrine function assessment in children with craniopharyngioma treated with stereotactic conformal radiotherapy Human neural stem cells can target and deliver therapeutic genes to breast cancer brain metastases Steroid Requirements during Radiotherapy for Malignant Gliomas Mutational profiling of high grade gliomas reveals inactivating mutations in IDH1 Genomic Profiling of Intracranial Germ Cell Tumors with Single Nucleotide Polymorphism Array PRESENCE OF AN ALTERNATIVE LENGTHENING OF TELOMERE (ALT) MECHANISM AS A FAVORABLE PROGNOSTIC MARKER IN PATIENTS WITH GLIOBLASTOMA Long Term Follow Up of Patient with Acromegaly after LINAC Radiosurgery DO MEDULLOBLASTOMAS IN ADOLESCENTS HAVE A DISTINCT MOLECULAR SIGNATURE & Aberrant expression of GDF-15 contributes to proliferation and immune escape of malignant gliomas Personalized chemotherapy based on O6-methylguanine-DNAmethyltransferase (MGMT) expression pattern for CDK4/6 SMALL MOLECULE INHIBITOR PD-0332991 DEMONSTRATES ANTI-TUMOR ACTIVITY AGAINST AN INTRACRANIAL GLIOBLASTOMA XENOGRAFT LACKING p16 FUCNTION PATIENT-SPECIFIC VIRTUAL CONTROLS CAN BE USED TO SIMULATE AND PREDICT RESPONSE TO RADIATION THERAPY IN INDIVIDUAL GLIOBLASTOMA PATIENTS Autophagy Induced by Valproic Acid is Associated with Oxidative Stress in Glioma Cell Lines Management of pituitary adenoma with stereotactic radiotherapy at Princess Margaret Hospital.
Genomewide Analysis of Loss of Heterozygosity in Glioblastoma using the SNP mapping array and the PCR Molecular allelokaryotyping of malignant glioma by high-resolution single nucleotide polymorphism (SNP) An ANOCEF genomic and transcriptomic microarray study of the response to radiotherapy or to alkylating first- line chemotherapy in glioblastoma patients.
Selective Expression of a Subset of Neuronal Genes in Oligodendrogliomawith Chromosome 1p Loss LOSS OF HETEROZIGOSITY AT 1p-19q INDUCES A GLOBAL CHANGE IN OLIGODENDROGLIAL Functional analysis of the proteome related to the chemotherapy sensitivity in anaplastic oligodendroglioma and Establish the overall proteins reference database of human normal pituitary using 2D-HPLC combined with CD52 protein may be a potential tumor marker of hemangioblastoma in central nerval systerm with cDNA microarray filtration of the gene expression profiles Genome-wide analysis of gene expression during brain metastasis formation Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1α Effects of hypoxia on expression of a panel of stem cell and chemosensitivity markers in glioblastoma cell line- Cell motility features are identified in the CD133-positive glioma and endothelial progenitor cells GLIOBLASTOMA TUMOUR INITIATING CELLS DEMONSTRATE VEGF BUT NOT PDGF Establishment of artificial Glioblastoma initiating cells in mouse CD133 ON STEM CELLS IS REQUIRED FOR APOPTOTIC INDUCTION IN GLIOMAS Tumor stem-like associated antigens and their irradiations improve the effect of dendritic cell-based vaccination Immunosuppressive B7-H1 Protein is Expressed by Differentiated Glioma Cells but not Glioma Stem Cells B7-H1 is correlated with the malignancy grade of human astrocytic tumors but it is not the privilege of brain EXPRESSION LEVEL OF STEM CELL MARKERS IS ASSOCIATED WITH THE SOURCE OF NEUROSPHERE MEDIA USED FOR GLIOBLASTOMA STEM CELL CULTURE.
AN EVALUATION OF THE NEURAL STEM CELL MARKER NG2 AS A BIOMARKER OF DISEASE IN Gene Therapy Using TRAIL-Secreting Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells against Brain Easy Analysis Tool For 201Tl SPECT in Brain Tumors 123I-IMP SPECT in Brain Tumor: Anatomical Standardized Statistical Mapping The application of Susceptibility Weighted magnetic resonance Imaging (SWI) to diagnosis and treatment of Choline-enhanced proton MRS of brain tumors Preoperative evaluation by proton magnetic resonance spectroscopy in the grading of gliomas Modified 11C-Methionine PET imaging to distinguish radiation necrosis from recurrent glioma Matching analysis of PET and chemical shift imaging on proton MRS in patients with supratentorial glioma Augmenting Intraoperative MRI with Preoperative DTI and fMRI by Simulation of Brain Deformation Using Mathematical Model Based on Thin-Plate Splines:A Preliminary Research The Value of rCBV Ratio in Perfusion MR for Differentiating Radiation Necrosis from Tumor Recurrence in High Grade Glioma; comparison with 18F-FDG and 11C-Methionine PET Evaluation of glioma grading on MR imaging: Diagnostic value of minimum apparent diffusion coefficient compared with positron-emission tomography Glioblastoma treated with postoperative radio-chemotherapy: Prognostic value of apparent diffusion coefficient DIFFUSION-WEIGHTED IMAGING IN PATIENTS WITH GLIOBLASTOMA MULTIFORME TREATED Evaluation of anti-angiogenic therapy response in patients with GBM; a Homodynamic Response Imaging study PROGNOSTIC SIGNIFICANCE OF GROWTH KINETICS IN NEWLY DIAGNOSED GLIOBLASTOMA: A ROLE FOR PATIENT-SPECIFIC VIRTUAL CONTROLS Effectiveness of Gorei-San ( Wuling San ) for eliminating brain edema due to malignant brain tumors Image guided Convection-enhanced delivery of nimustine hydrochloride (ACNU) in recurrent glioma patients Convection enhanced delivery of nimustine hydrochloride (ACNU) with systemic administration of temozolomide in recurrent glioma patients SURVIVAL OF PATIENTS WITH GLIOBLASTOMA MULTIFORME AT HARTFORD HOSPITAL SINGLE CENTER SURVIVAL OUTCOMES OF 167 GLIOBLASTOMA PATIENTS: BEFORE AND Clinical outcomes of adult supratentorial grade 3 malignant gliomas in a single institution Glucocorticoid-induced bone fracture in progressive glioma patients NEWLY DIAGNOSED PREGNACY AND GLIOBLASTOMA MULTIFORME (GBM): AN ETHICAL Vntricular and Leptomeningeal Seeding in a Patient with Medullary Anaplastic Oligodendroglioma Long-term outcome of low-grade gliomas treated with radiotherapy-deferring therapeutic policy Considerations for diagnosis and treatment of classical gliomatosis cerebri Growth rates of metastatic brain tumors in non-small cell lung cancer; estimation from micro-metastasis Prognostic factors in 57 patients with metastastic brain tumors from breast cancer.
Intramedullary spinal cord metastasis in breast carcinoma, case report.
Spinal cord metastasis of adenocarcinoma, case Report Complete response of a large recurrent metastatic brain tumor treated by CyberKnife: a case report and review Continuous intrathecal treatment with methotrexate via "Ventricular port" for leptomeningeal dissemination of Population Based Epidemioly of Central Nervous System (CNS) malignancies in the Girona province (Spain).
Results of an 11 years survey (1994-2004).
THE FIRST FINGERPRINTS OF NEUROONCOLOGY IN PREHISTORIC ERA; PREHISTORIC TRAPENATED SKULLS MAY BE THE FIRST ATTACT TO TREAT TUMORS IN NEUROONCOLOGY Expanded Endonasal Resection of Supra- and Extra-Sellar Lesions Extended endoscopic endonasal transsphenoidal approach for skull base lesion- Availability of multilayered Results of Extended TSA to anterior skull base Two-Surgeons Technique for infratemporal fossa tumor; Simultaneous lateral transzygomatic and endoscopic Application of Endoscopes in minimally invasive neurosurgery Clinical correlation between peritumoral edema and various factors in meningioma.
Meningioma operations in the elderly patients: efficient way to internal decompression A 57-patient experience on the surgical strategies of petroclival meningiomas Retrospective analysis of the post-operative outcome of petroclival meningiomas Advantages of the Pterional approach for Olfactory groove and Tuberculum Sellae Meningiomas Meningioma arising from the lateral recess of 4th ventricle Surgical management for trigeminal schwannoma Lateral or anterolateral approach for large dumbbell-shaped cervical neurinoma Clinical Course of Piuitary Adenoma after Apoplexy Efficacy and Safety of Cabergoline as a First Line Treatment for Invasive Giant Male Prolactinoma Comparison of lateral and superior walls of the pituitary fossa with clinical emphasis on pituitary adenoma METASTATIC ACTH PRODUCING PITUITARY CARCINOMA (PCa) TREATED WITH TEMOZOLOMIDE(T): CASE REPORT AND REVIEW OF THE LITERATURE Isolated Ocular Paresis in the Pituitary Adenoma: Review of 4 cases The effective treatment of craniopharyngioma using highly conformal hypofractionated stereotactic irradiation Lymphocytic hypophysitis with reference to MR imaging Central Neurocytoma Presenting with Intraventricular Hemorrhage Clinical Treatment of Intracranial Malignant Nerve Sheath Tumors A rare tumor-like lesion of peripheral nerve sheath in an unusual site. Neuromuscular choristoma of intraorbital retrobulbar conus. A case report and literature review.
Clinical Experiences Of Intracranial Hemangioblastoma Surgical management of CNS hemangioblastomas in von Hippel-Lindau disease Clinical Diagnosis and Treatment of Hypothalamic Hamartoma in Children Clinical Diagnosis and Treatment of Third Ventricle Cavernous Angioma MULTIFOCAL, PROTEINACEOUS CNS DEPOSITS MIMICKING NEOPLASIA: REPORT OF AN UNUSUAL CEREBRAL AND CEREBELLAR AMYLOIDOMA WITH LONG LASTING CLINICALHISTORY Primary Burkitt lymphoma of CNS in an immunocompetent old woman: a rare case report and review literatures Primary leptomeningeal melanomatosis in a 31-year-old woman Primary Intracerebral Malignant Fibrous Histiocytoma, Case report Incidentally discovered Clival Pseudomeningocele : A Case Report Malignant brain tumor in a patient with AIDS Glioblastoma developed in a cured pediatric CNS leukemia A PATIENT WITH GLIOBLASTOMA MULTIFORME AND A LEFT CERVICAL MASS- A CASE Early detection of the venous thromboembolism in glioma patient 2 CASES OF EXTRADURAL GLIOBLASTOMA MULTIFORME PRESENTING AS TRIGEMINAL NEURALGIA; PATTERNS OF MOLECULAR TARGETS OF INVASIVENESS.
Pontine Cryptococal granuloma in a healthy, non-immunocompromised patient-Case report- Prognositic analysis of 220 patients with intramedullary spinal cord ependymomas The Rational Neurosurgical Treatment of pineal region tumors Conservative Management of Pseudomeningoceal Formation after Posterior Fossa Tumor Surgery in Children Posterior Fossa Tumors with Hydrocephalus: Outcome of Surgery without CSF Diversion Atypical meningioma in French West Indies Atypical Rathke’s cleft cyst with calcification May14 (Thu)
The correlation and prognostic significance of MGMT promoter methylation and the MGMT protein in Relevance of MSP assay for the detection of MGMT promoter hypermethylation in glioblastomas Clinical significance of polymorphism of DNA repair gene MGMT in Glioblastomas IMMUNOHISTOCHEMICAL ASSESSMENT OF O6-METHYLGUANINE DNA METHYLTRANFERASE MGMT methylation status may predict survival in elderly patients with newly diagnosed glioblastoma (GBM) Methylation-sensitive high resolution melting analysis :a new quantitative assessment of MGMT promoter MGMT testings for temozolomide efficacy on glioblastoma A NOVEL AND SPECIFIC INHIBITOR OF MGMT TRANSCRIPTION INCREASES THE SENSITIVITY OF GLIOMA CELL LINES TO TEMOZOLOMIDE TREATMENT.
Mechanism of Thalidomide to enhance the cytotoxicity of Temozolomide in U251-MG glioma cells in vitro Neural differentiation markers expression in human glioblastomas may predict their response to chemotherapy Extended use of temozolomide based on O6-methylguanine-DNAmethyltransferase (MGMT) expression pattern for glioma patients: experience of 17 cases Pysosequencing: a good option for MGMT analysis.
ANGIOGENIC POTENTIAL OF LOW GRADE OLIGODENDROGLIOMAS IS AN IMPORTANT Identification of a novel small molecule HIF-1α translation inhibitor PHASE I STUDY OF VANDETANIB, IMATINIB MESYLATE AND HYDROXYUREA FOR A PHASE I STUDY OF SUNITINIB PLUS IRINOTECAN IN THE TREATMENT OF PATIENTS WITH A PHASE IB TRIAL OF CEDIRANIB IN ADDITION TO STANDARD TEMOZOLOMIDE AND RADIATION THERAPY IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA THE POTENTIAL BENEFIT OF NEOADJUVANT AND EXTENDED-ADJUVANT TEMOZOLAMIDE WITH THE STUPP-REGIMEN IN THE TREATMENT OF GLIOBLASTOMA Dose dense one week on/ one week off temozolomide in recurrent glioma.
CLINICAL TRIAL WITH TEMOZOLOMIDE IN AN ALTERNATING WEEKLY REGIMEN AGAINST RECURRENT MALIGNANT GLIOMAS-A PRELIMINARY REPORT Safety and efficacy of near-continuous dose-dense temozolomide (Tegwondo) for recurrent gliomas Pharmaceutical control of temozolomide chemotherapy with original leaflets and administration history Safety and efficacy of temozolomide treatment with newly diagnosed glioblastoma in Japan. A multicenter RETROSPECTIVE ANALYSIS OF GLIOBLASTOMA (GBM) PATIENTS TREATED WITH TEMOZOLOMIDE (TMZ)-RADIOTHERAPY FOLLOWED BY TMZ FOR 2 YEARS OR UNTILPROGRESSION: SURVIVAL ANALYSIS Pseudprogression or tumor progression in gliomas: what kinds of diagnostic tools are more reliable? Hypofractionated high-dose irradiation by IMRT concurrent with prophylactic intrathecal chemotherapy for the A Pilot Safety Trial of Hypofractionated Radiation Therapy plus Concomitant and Adjuvant Temozolomide for Upfront chemotherapy for gliomas deleting 1p and 19q followed by second-look removal and/or radiotherapy at Benefit of Chemotherpy in Anaplastic Astrocytomas Therapy-related myelodysplastic syndrome following treatment for malignant glioma Teniposide and Nimustine Regimen for Malignant Gliomas with O6-methylguanine-DNA methyltransferase (MGMT) Negative Expression: Experience of 18 cases Safety profile of carmustine wafer treatment in first line treatment of malignant glioma with carmustine implants followed by concomitant radiochemotherapy THE GROWTH PATTERN OF RECURRENT GLIOBLASTOMA AFTER GLIADEL(TM) WAFER Pre-radiation chemotherapy with ACNU-CDDP in patients with newly diagnosed glioblastoma: a retrospective A concurrent association radiation therapy fotemustine for newly diagnosed malignant gliomas, a phase II.
TOXICITY PROFILE OF VALPROATE AND ETOPOSIDE METRONOMIC CHEMOTHERAPY Combination therapy with carboplatin and etoposide for recurrent malignant gliomas Phase II Study of Ifosfamide, Carboplatin and Etoposide for Patients with Glioblastoma at first relapse PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN PATIENTS WITH BRAINSTEM Treatment of primary malignant gliomas and meningiomas with ruta/calc phos Leptomeningeal gliomatosis in patients treated with bevacizumab Response to intrathecal infusions of Depocyte in secondary diffuse leptomeningeal gliomatosis. A case report.
New therapeutic approach for brain tumors: intranasal administration of Ras inhibitor monoterpene perillyl Cetuximab does not influence Serum Magnesium Homeostasis in Patients with Glioblastoma Multiforme treated with concomitant Radiotherapy and Temozolomide A retrospective single institutional analysis of cilengitide (CGT) and chemotherapy for heavily pre-treated recurrent glioblastoma multiforme (GBM).
Cilengitide modulates attachment and viability of human glioma cells, but not sensitivity to irradiation or METABOLIC FACTORS GOVERN THE CYTOTOXIC POTENTIAL OF EGFR INHIBITION IN HUMAN AN EPIGENETIC GENOME-WIDE SCREEN IDENTIFIES THE SFRP FAMILY OF WNT SIGNALING INHIBITORS AS NOVEL TUMOR SUPPRESSOR GENES IN MEDULLOBLASTOMA SILENCING OF NEURONAL DIFFERENTIATION GENES REVEALED BY PROFILING THE Pediatric intracranial germ cell tumors of different prognosis outcomes and ethnic background inherit characteristic embryonic stem cell traits and microRNAome profiles The frequent expression of ARF-BP1 in primary intracranial germ cell tumors Frequent single nucleotide polymorphism (SNP) of BCL10 and association with poor prognosis in primary EXPRESSION PROFILES OF MICRORNA IN PEDIATRIC MALIGNANT GLIOMAS STRESS LEVELS AMONG PARENTS OF CHILDHOOD BRAIN TUMOR SURVIVORS MULTI-TIERED INTERVENTION STUDY FOR PATIENTS, CARERS AND HEALTH PROVIDERS TO ADDRESS CHALLENGING BEHAVIOURS AFTER BRAIN TUMOUR Knowledge and Attitudes On The Diagnosis, Treatment And Prognosis Among Patients With Brain Tumor And Management of Primary Malignant Brain Tumors During Pregnancy Cancer Stem Cells from Glioblastoma Multiforme Patients Characterization of Cancer Stem-like Cells Derived from Human Glioblastomas Characterization of cancer stem cells in human glioblastomas Characterization of tumor stem cells isolated form human glioblastoma multiforme STAT3 SERINE727 ACTIVATION IN GLIOMA CANCER STEM CELLS ENHANCEMENT OF STEM-LIKE GLIOMA NEUROSPHERE RADIORESPONSE BY GEFITINIB: BY INCREASED DNA DAMAGE AND REDUCED DNA REPAIR CAPACITY Inhibition of tumor growth and angiogenesis by targeting CXCL12/CXCR4 axis in stem cell-like glioma cells Cultivation and identification of the cells from central nervous system hemangioblastomas and its stem cells Screen and identify the critical proteins of central nervous system hemangioblastoma tumor cells using on-line capillary 2D-HPLC combined with LTQ-Orbitrap MS Notch1 induces more expression of DLL1 in U251MG glioma cell line The functional analysis of a novel KDR (VEGFR II)-PDGFR-alpha fusion gene in glioblastoma: From Isolation and Characterization of an N-Linked Oligosaccharide That Is Increased in Glioblastoma Tissue and Inhibition of glioma proliferation by modified p53 protein fused with protein transduction domains Expression of the lysosomal-associated membrane protein-1 (LAMP-1) in astrocytomas EVALUATION OF ELK-1 ACTIVATION BY PHOSPHATIDYLINOSITOL 3-KINASE/AKT PATHWAY ANTINEOPLASTONS INHIBIT MCM COMPLEX IN GLIOBLASTOMA CELLS Enhanced expression of NADPH Oxidase Nox4 in human gliomas and its roles in cell proliferation and survival EXPRESSION PATTERN OF EGFRS, INTEGRINS, AND RELATED MOLECULES IN HUMAN GLIOBLASTOMA VERSUS INTRACEREBRAL LUNG ADENOCARCINOMA METASTASIS Inhibition of LRIG3 gene expression via RNA interference modulates the proliferation, cell cycle, cell apoptosis, adhesion and invasion of glioblastoma cell Promyelocytic leukemia protein induces apoptosis by the repression of NFκB activation in glioblastoma The cellular oncogene ets-1 counteracts p53 tumour suppressor activity by affecting the level of p53 protein.
Cooperative cytotoxicity by HDAC inhibitors and RTKIs: induction of Cx43 in GBM cells A MDR1 (ABCB1) GENE SINGLE NUCLEOTIDE POLYMORPHISM PREDICTS OUTCOME OF TEMOZOLOMIDE TREATMENT IN GLIOBLASTOMA PATIENTS Diversity of DNA damage response of astrocytes and glioblastoma cell lines with various p53 status to treatment The decreased expression of GANP is associated with chromosomal instability in malignant gliomas ELK4 NEUTRALISATION SENSITISES HIGH GRADE GLIOMA TO APOPTOSIS THROUGH DOWN REGULATION OF THE ANTI-APOPTOTIC PROTEIN MCL-1 xCT as a potential molecular target in glioblastoma multiforme A novel MMAC/PTEN gene mutation in a GBM patient Attraction of hematopoietic progenitor cells by experimental gliomas in vivo: Towards a cell-based therapy for OLIGODENDROGLIOMAS WITH LOH 1P/19Q: IDENTIFYING GENES ASSOCIATED WITH ASSOCIATION OF 7q34 COPY NUMBER GAINS AND KIAA1549-BRAF GENE FUSIONS WITH IDH-1 mutations are frequent in low grade glioma and do not correlate with outcome to temozolomide PPAR-γ activators: Off-target against TGF-β mediated glioma cell migration and brain invasion Tight junction protein Occludin in human brain tumors: Radiological correlation and prognostic implication on Expression of the TIMP-1 interacting cell surface protein CD63 in astrocytomas Molecular Variations in Tumor-Host Interactions between Invasive and Angiogenic Phenotype in High Grade MULTI-MODAL IMAGING OF ACUTE AND CHRONIC UP-REGULATION OF HYPOXIA-INDUCIBLE Relationship between ABC transporter proteins and vasculogenesis in glioblastomas Histone deacetylase inhibitor, valproic acid inhibits glioma angiogenesis in vitro and in vivo in the brain The p14ARF tumor suppressor inhibits Glioma-Induced Angiogenesis by a Novel Mdm2/Sp1/Timp3 Signaling Dicer-regulated microRNAs 222 and 339 promote resistance of cancer cells to cytotoxic T-lymphocytes by Hypoxia-induced Stat3 activity contributes the HIF-1, VEGF, MMP2 and TWIST expression in human glioblastoma, which induce angiogenesis and cell migration.
NOVEL MONOCLONAL ANTIBODY 13R2.C3 AGAINST IINTERLEUKIN 13 RECEPTOR ALPHA-2 REVEALS A SPECIFIC AND MORE WIDE-SPREAD EXPRESSION OF THE RECEPTOR IN VARIOUSBRAIN TUMORS Synergistic effect of human IFN-beta and TMZ on malignant glioma cell lines The role of chemokine SDF-1/CXCR4/CXCR7 for glioblastoma angiogenesis and glioblastoma derived Soluble CD70 Confers an Immune-Mediated Survival Advantage in Experimental Glioblastoma Aberrant Hypermethylation of CpG islands Profile of Cell Cycle Regulatory Genes in Malignant Astrocytomas An in vitro study of selected synthetic chalcone analogues activity against Ben-Men-1 meningioma cell line New CCM1 gene mutations in Chinese sporadic intracranial cavernous angioma patients The functional role of eIF4E in primary central nervous system lymphoma Is it Total removal of glioblastoma possible? - tumor cell infiltration from autopsy brain Clinical significance of vasculogenic mimicry in human gliomas Validation of prognostic and therapeutic worth of molecular markers by routine tools in diagnostic and clinical neuropathology: a study of 193 glioblastomas.
OLIGODENDROGLIAL TUMOR CLASSIFICATION: PHENOTYPE vs GENETIC SIGNATURE HISTOLOGIC ANAPLASIA IN SPORADIC AND NF1-ASSOCIATED PILOCYTIC ASTROCYTOMAS APPLICATION OF A CYTOGENETC PROGRESSION SCORE (GPS), TUMOR LOCATION AND GENETIC PROGRESSION IN MENINGIOMAS: HACETTEPE EXPERIENCE Targeting the tumor stroma a novel therapeutic strategy based on separate analysis of the malignant and stromal Therapeutic efficacy of a polymeric micellar doxorubicin infused by convection-enhanced delivery against Label-free Differentiation of individual human glioma cells by optical FTIR spectroscopic imaging Application of multiple-stage tandem imaging mass spectrometry to the evaluation of lipids in a rat brain C6 Spectroscopic imaging of cerebral micrometastases in a murine model Significance of NMR based metabolomics (metabolome) for the prediction of malignant type meningioma using the analysis of water and lipid-soluble metabolites Role of Proteomic study of CSF as a diagnostic tool in the patients with meningiomas IL-6 in meningioma; Expression is correlated with peritumoral edema and VEGF Antitumor effect of humanized anti-IL-6 receptor antibody (tocilizumab) on glioma cell proliferation The Plasma Concentration of ET-1 in the Brain Tumors Plasma Ig E levels correlate with diagnosis and response to therapy in glioma patients Promoter methylation profiles of six tumor-related genes in various brain tumors SHORT COURSE OF RADIOTHERAPY AND CONCOMITANT TEMOZOLOMIDE IN PATIENTS AFFECTED WITH GLIOBLASTOMA WITH V-VI PROGNOSTIC CLASSES. A PILOT STUDY Assessment of 11C-methionine PET Changes for Monitoring Therapeutic Response Following Simultaneous Integrated Boost Technique for Glioblastoma Multiforme RECURRENCE PATTERN AFTER [(18)F]FLUOROETHYLTYROSINE- POSITRON EMISSION TOMOGRAPHY-GUIDED RADIOTHERAPY FOR HIGH-GRADE GLIOMA.
Rhabdomyosarcoma as a late complication of Stereotactic Radiotherapy in the patient with Neurofibromatosis RADIATION-INDUCED CEREBRAL CAVERNOUS HEMANGIOMAS IN ADULTS.
Hematotoxicity of craniospinal irradiation in adult patients Inspection about recurrence and progressing dementia after WBRT to metastatic brain tumor - Problem Novalis Shaped Beam Radiosurgery for cranial and spinal tumors: 8 years of experience in Korea ULTRAFRACTIONATED RADIATION THERAPY (3 DOSES PER DAY) FOR INOPERABLE GLIOBLASTOMAS. A NEW AND PROMISING REGIMEN.
STEREOTACTIC RADIOSURGERY (SRS) IN RECURRENT HIGH-GRADE GLIOMA Treated with CyberKnife Stereotactic Radiosurgery: Two CyberKnife Centers Experience Peritumoral edema after Cyberknife radiosurgery for meningioma: Report of two cases and Review of literature.
Preliminary results of initially trated patients-FEASIBILITY OF APPLYING THE SYNERGY-S SYSTEM FOR STEREOTACTIC IRRADIATION SPINAL TUMORS DOSE-VOLUME ANALYSIS OF WHOLE VENTRICULAR IRRADIATION BY PROTON BEAM COMPARING WITH INTENSITY MODULATED RADIOTHERAPY AND STANDARD PHOTONTHERAPY IN VIVO BIODISTRIBUTION OF BORON AFTER INTRAVENOUS 4- DIHYDROXYBORYLPHENYLALANINE-FRUCTOSE (BPA-F) INFUSION IN MENINGIOMA ANDSCHWANNOMA: A FEASIBILITY STUDY FOR BORON NEUTRON CAPTURE THERAPY(BNCT) Clinical Results of Modified Boron Neutron Capture Therapy for Malignant Glioma BRAIN TUMORS BRACHYTHERAPY BY USING RIGID IR192 CATHETER IMAGING FEATURES IN PARENCHYMAL LYMPHOMATOUS MASSES IN BRAIN: PRIMARY CNS LYMPHOMA OR SYSTEMIC INVOLVEMENT OF THE BRAIN? Long-term Survival in Primary CNS Lymphoma Treated by High-dose Methotrexate Monochemotherapy: role of STAT6 Activation as prognostic determinant Treatment for primary CNS lymphoma with high-dose MTX and salvage therapy with ESHAP Treatment of Primary Central Nervous System Lymphoma with Temozolomide, Vincristine, Doxorubicin, Intravenous rituximab combined with temozolomide as a second line therapy for CD20 positive primary central Maintenance therapy using rituximab for primary central nervous system lymphoma Diagnosis and Management of Spinal Extradural Non-Hodgkin Lymphoma:Analysis of Three Cases and Review
Should echinacea be taken on a daily basis?The question whether echinacea should be used on along-term or continual basis has not been adequatelyanswered. The usual recommendation with long-termuse is 8 weeks on followed by one week off. Researchsuggests that the people most likely to benefit fromusing echinacea for prevention are those with weakerimmune systems who are more prone to infection.